The complete dna sequence of myxoma virus

Virology

Volumn 264, Issue 2, 1999, Pages 298-318

  Cameron, Cheryl ^a,b   Hota Mitchell, Sheela ^b   Chen, Ling ^b   Barrett, John ^b   Cao, Jing Xin ^b   Macaulay, Colin ^c   Willer, David ^d   Evans, David ^d   McFadden, Grant ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c Viron Therapeutics Inc   (Canada)

^d UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN;

ANTIVIRAL ACTIVITY; ARTICLE; DATA BASE; DISEASE SEVERITY; DNA SEQUENCE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MYXOMATOSIS; NATURAL KILLER CELL; POXVIRUS; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SPECIES DIFFERENTIATION;

EID: 0033604517     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0001     Document Type: Article

References (88)

1. Afonso C. L., Tulman E. R., Lu Z., Oma E., Kutish G. F., Rock D. L. The genome of Melanoplus sanguinipes Entomopoxvirus. J. Virol. 73:1999;533-552.
2. Ahn B. Y., Moss B. Glutaredoxin homolog encoded by vaccinia virus is a virion-associated enzyme with thioltransferase and dehydroascorbate reductase activities. Proc. Natl. Acad. Sci. USA. 89:1992;7060-7064.
3. Altschul S. F., Madden T. L., Schaffer A. A., Zhang J., Zhang Z., Miller W., Lipman D. J. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
4. Antoine G., Scheiflinger F., Dorner F., Falkner F. G. The complete genomic sequence of the modified vaccinia Ankara strain: Comparison with other orthopoxviruses. Virology. 244:1998;365-395.
5. Bais C., Santomasso B., Coso O., Arvanitakis L., Raaka E. G., Gutkind J. S., Asch A. S., Cesarman E., Gershengorn M. C., Mesri E. A. G-protein coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature. 391:1998;86-89.
6. Baldick C. J., Keck J. G., Moss B. Mutational analysis of the core, spacer and initiator regions of vaccinia virus intermediate-class promoters. J. Virol. 66:1992;4710-4719.
7. + T lymphocytes. J. Virol. 69:1995;5243-5251.
8. Beaud J. F. Vaccinia virus DNA replication: A short overview. Biochimie (Paris). 77:1995;774-779.
9. Berson J. F., Doms R. W. Structure-function studies of the HIV-1 coreceptors. Semin. Immunol. 10:1998;237-248.
10. Biron C. A., Nguyen K. B., Pien G. C., Gousens L. P., Salazar-Mather T. P. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu. Rev. Immunol. 17:1999;189-220.
11. Blasco R., Sisler J. R., Moss B. Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: Effect of a point mutation in the lectin homology domain of the A34R gene. J. Virol. 67:1993;3319-3325.
12. Boshkov L. K., Macen J. L., McFadden G. Virus-induced loss of class I major histocompatibility antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus. J. Immunol. 148:1992;881-887.
13. Brick D. J., Burke R. D., Schiff L., Upton C. Shope fibroma virus RING finger protein N1R binds DNA and inhibits apoptosis. Virology. 249:1998;42-51.
14. Bucher P., Bairoch A. A generalized profile syntax for biomolecular sequences motifs and its function in automatic sequence interpretation. Altman R., Brutlag D., Karp P., Lathrop R., Searls D. Intelligent Systems for Molecular Biology 1994. 1994;AAAI Press, Menlo Park.
15. Cabirac G. F., Strayer D. S., Sell S., Leibowitz J. L. Characterization, molecular cloning, and physical mapping of the Shope fibroma virus genome. Virology. 143:1985;663-670.
16. Chang H. Y., Nishitoh H., Yang X. L., H. I., Baltimore D. Activation of apoptosis signal regulating kinase 1 (ASK1) by the adapter protein DAXX. Science. 281:1998;1860-1863.
17. Chang H. Y., Yang X., Baltimore D. Dissecting Fas signaling with an altered-specificity death-domain mutant: Requirement of FADD binding for apoptosis but not Jun N-terminal kinase activation. Proc. Natl. Acad. Sci. USA. 96:1999;1252-1256.
18. Davison A. J., Moss B. Structure of vaccinia virus early promoters. J. Mol. Biol. 210:1989;749-769.
19. Davison A. J., Moss B. New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins. Nucleic Acids Res. 18:1990;4285-4286.
20. Duncan S. A., Smith G. L. Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. J. Virol. 66:1992;1610-1621.
21. Esposito J., Condit R., Obijeski J. The preparation of orthopoxvirus DNA. J. Virol. Methods. 2:1981;175-179.
22. Fenner F. Portraits of viruses: The poxviruses. Intervirology. 11:1979;137-157.
23. Fenner F. Biological control, as exemplified by smallpox eradication and myxomatosis. Proc. R. Soc. Lond. 218:1983;259-285.
24. Fenner F., Ratcliffe F. N. Myxomatosis. 1965;Cambridge University Press, Cambridge.
25. Goebel S. J., Johnson G. P., Perkus M. E., Davis S. W., Winslow J. P., Paoletti E. The complete DNA sequence of vaccinia virus. Virology. 179:1990;247-266.
26. Gorczynski L., Chen Z., Hu J., Kai Y., Lei J., Ramakrishna V., Gorcynski R. M. Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells. J. Immunol. 162:1999;774-781.
27. Gorczynski R. M., Chen Z., Fu X.-M., Zeng H. Increased expression of the novel molecule OX-2 is involved in prolongation of murine renal allograft survival. Transplantation. 65:1998;1106-1114.
28. Graham K. A., Opgenorth A., Upton C., McFadden G. Myxoma virus M11L ORF encodes a protein for which cell surface localization is critical for manifestation of viral virulence. Virology. 191:1992;112-124.
29. Gvarkharia B. O., Koonin E. K., Mathews C. K. Vaccinia virus G4L gene encodes a second glutaredoxin. Virology. 226:1996;408-411.
30. Hebert T. E., Bouvier M. Structural and functional aspects of G protein-coupled receptor oligomerization. Biochem. Cell Biol. 76:1998;1-11.
31. Hofmann K., Bucher P., Falquet L., Bairoch A. The PROSITE database: Its status in 1999. Nucleic Acids Res. 27:1999;215-219.
32. Horton, P, and, Nakai, K. 1996, A probabilistic classification system for predicting the cellular localization sites of proteins, In, Intelligent Systems for Molecular Biology, AAAI Press, Menlo Park, CA.
33. Horton, P, and, Nakai, K. 1997, Better prediction of protein cellular localization sites with the k Nearest Neighbors Classifier, In, Intelligent Systems for Molecular Biology, 5, AAAI Press, Menlo Park, CA.
34. Jackson R. J., Hall D. F. The myxoma virus Ecori-O fragment encodes the DNA binding core protein and the major envelope protein of extracellular poxvirus. Virus Genes. 17:1998;55-62.
35. Jackson R. J., Hall D. F., Kerr P. J. Myxoma virus encodes an alpha 2,3-sialytransferase that enhances virulence. J. Virol. 73:1999;2376-2384.
36. Johnson G. P., Goebel S. J., Paoletti E. An update on the vaccinia virus genome. Virology. 196:1993;381-401.
37. Kerr P. J., Best S. M. Myxoma virus in rabbits. Rev. Sci. Tech. 17:1998;256-268.
38. Kyte J., Doolittle R. F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:1982;105-132.
39. Lambert S., Hullan Y., Prchal J. T., Lawler J., Ruff P., Speicher D., Cheung M. C., Kan Y. W., Palek J. cDNA sequence for human erythrocyte ankyrin. Proc. Natl. Acad. Sci. USA. 87:1990;1730-1734.
40. Lanier L. L. NK cell receptors. Annu. Rev. Immunol. 16:1998;359-393.
41. Lindberg F. P., Bullard D. C., Caver T. E., Gresham H. D., Beaudet A. L., Brown E. J. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science. 274:1996;795-798.
42. Locati M., Murphy P. M. Chemokines and chemokine receptors: Biology and clinical relevance in inflammation and AIDS. Annu. Rev. Med. 50:1999;425-440.
43. Lopez-Botet M., Bellon T. Natural killer cell activation and inhibition by receptors for MHC class I. Curr. Opin. Immunol. 11:1999;301-307.
44. Lucas A., Liu L.-Y., Macen J., Nash P., Dai E., Stewart M., Graham K., Etches W., Boshkov L., Nation P. N., Humen D., Lundstrom-Hobman M., McFadden G. Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty. Circulation. 94:1996;2890-2900.
45. Macaulay C., McFadden G. Tumorigenic poxviruses: Characterization of an early promoter from Shope fibroma virus. Virology. 172:1989;237-246.
46. Macen J. L., Upton C., Nation N., McFadden G. SERP-1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology. 195:1993;348-363.
47. Martin K. H., Grosenbach D. W., Franke C. A., Hruby D. E. Identification and analysis of three myristylated vaccinia virus late proteins. J. Virol. 71:1997;5218-5226.
48. Massung R. F., Liu L. I., Qi J., Knight J. C., Yuran T. E., Kerlavage A. R., Parsons J. M., Venter J. C., Esposito J. J. Analysis of the complete genome of smallpox variola major virus strain Bangladesh-1975. Virology. 201:1994;215-240.
49. McFadden G., Barry M. How poxviruses oppose apoptosis. Semin. Virol. 8:1998;429-442.
50. McFadden G., Graham K., Ellison K., Barry M., Macen J., Schreiber M., Mossman K., Nash P., Lalani A., Everett H. Interruption of cytokine networks by poxviruses: Lessons from myxoma virus. J. Leuk. Biol. 57:1995;731-738.
51. McIntosh A. A. G., Smith G. L. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J. Virol. 70:1996;272-281.
52. Messud-Petit F., Gelfi J., Delverdier M., Amardeilh M.-F., Py R., Sutter G., Bertagnoli S. SERP-2, an inhibitor of the interleukin-1β-converting enzyme, is critical in the pathobiology of myxoma virus. J. Virol. 72:1998;7830-7839.
53. Moss B. Poxviridae: The viruses and their replication. Fields B. N., Knipe D. M., Howley P. M. Fundamental Biology. 1996;Lippincott-Raven Publishers, Philadelphia.
54. Mossman K., Lee S. F., Barry M., Boshkov L., McFadden G. Disruption of M-T5, a novel myxoma virus gene member of the poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J. Virol. 70:1996;4394-4410.
55. Murphy P. M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:1994;593-633.
56. Nash P., Barrett J., Cao J.-X., Hota-Mitchell S., Lalani A. S., Everett H., Xu X.-M., Robichaud J., Hnatiuk S., Ainslie C., Seet B. T., McFadden G. Immunomodulation by viruses: The myxoma virus story. Immunol. Rev. 168:1999;103-120.
57. Nash P., Lucas A., McFadden G. SERP-1, a poxvirus-encoded serpin, is expressed as a secreted glycoprotein that inhibits the inflammatory response to myxoma virus infection. Church F. C., Cunningham D. D., Ginsburg D., Hoffman M., Stone S. R., Tollefsen D. M. Chemistry and Biology of Serpins. 1997;195-205 Oxford University Press, New York.
58. Nash P., Whitty A., Handwerker J., Macen J., McFadden G. Inhibitory specificity of the anti-inflammatory myxoma virus serpin, SERP-1. J. Biol. Chem. 273:1998;20982-20991.
59. Oguiura N., Spehner D., Drillien R. Detection of a protein encoded by the vaccinia virus C7L open reading frame and study of its effect on virus multiplication in different cell lines. J. Gen. Virol. 74:1993;1409-1413.
60. Parkinson J. E., Sanderson C. M., Smith G. L. The vaccinia virus A38L gene product is a 33kDa integral membrane glycoprotein. Virology. 214:1995;177-188.
61. Perkus M. E., Goebel S. J., Davis S. W., Johnson G. P., Limbach K., Norton E. K., Paoletti E. Vaccinia virus host range proteins. Virology. 179:1990;276-286.
62. Petit F., Bertagnoli S., Gelfi J., Fassy F., Boucraut-Baralon C., Milon A. Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1β converting enzyme. J. Virol. 70:1996;5860-5866.
63. Pettersen R. d., Hestdal K., Olafsen M. K., Lie S. O., Lindberg F. P. CD47 signals T cell death. J. Immunol. 162:1999;7031-7040.
64. Porter J. C., Hogg N. Integrins take partners: Cross-talk between integrins and other membrane receptors. Trends Cell Biol. 8:1998;390-396.
65. Premack B. A., Schall T. J. Chemokine receptors: Gateways to inflammation and infection. Nat. Med. 2:1996;1174-1178.
66. Rodriguez-Frade J. M., Vila-Coro A. J., de Ana A. M., Albar J. P., Martinez A. C., Mellado M. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor, CCR2. Proc. Natl. Acad. Sci. USA. 96:1999;3628-3633.
67. Roper R. L., Payne L. G., Moss B. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J. Virol. 70:1996;3753-3762.
68. Roper R. L., Wolffe E. J., Weisberg A., Moss B. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J. Virol. 72:1998;4192-4204.
69. Rosenkilde M. M., Kledal T. N., Brauner-Osborne E., Schwartz T. W. Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74. J. Biol. Chem. 274:1999;956-961.
70. Röttger S., Frischknecht F., Reckmann I., Smith G. L., Way M. Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J. Virol. 73:1999;2863-2875.
71. Russell R. J., Robbins S. J. Cloning and molecular characterization of the myxoma virus genome. Virology. 170:1989;147-159.
72. Russo J. J., Bohenzky R. A., Chien M. C., Chen J., Yan M., Maddalena D., Parry J. P., Peruzzi D., Edelman I. S., Chang Y. A., Moore P. S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA. 93:1996;14862-14867.
73. Sanderson C. M., Frischknecht F., Way M., Hollinshead M., Smith G. L. Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. J. Gen. Virol. 79:1998;1415-1425.
74. Sanderson C. M., Parkinson J. E., Hollinshead M., Smith G. L. Overexpression of the vaccinia virus A38L integral membrane protein promotes Ca2+ influx into infected cells. J. Virol. 70:1996;905-914.
75. Schultz J., Milpetz F., Bork P., Ponting C. P. SMART, a simple modular architecture research tool: Identification of signalling domains. Proc. Natl. Acad. Sci. USA. 95:1998;5857-5864.
76. Senkevich T. G., Koonin E. V., Bugert J. J., Darai G., Moss B. The genome of Molluscum contagiosum virus: Analysis and comparison with other poxviruses. Virology. 233:1997;19-42.
77. Senkevich T. G., Wolffe E. J., Buller R. M. L. Ectromelia virus RING finger protein is localized in virus factories and is required for virus replication in macrophages. J. Virol. 69:1995;4103-4111.
78. Shchelkunov S. N., Massung R. F., Esposito J. J. Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola viruses. Virus Res. 36:1995;107-118.
79. Smith G., Chan Y. S. Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily. J. Gen. Virol. 72:1991;511-518.
80. Spriggs M. K., Hruby D. E., Maliszewski C. R., Pickup D. J., Sims J. E., Buller R. M., VanSlyke J. Vaccinia and cowpox viruses encode a novel secreted interleukin-1 binding protein. Cell. 71:1992;145-152.
81. Strader C. D., Fong T. M., Tota M. R., Underwood D., Dixon R. A. Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63:1994;101-132.
82. Turner P. C., Moyer R. W. The control of apoptosis by poxviruses. Semin. Virol. 8:1998;453-469.
83. Turner P. C., Sancho M. C., Theonnes S. R., Caputo A., Bleackley R. C., Moyer R. W. Myxoma virus SERP-2 is a weak inhibitor of granzyme B and interleukin-1β-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virus-infected cells. J. Virol. 73:1999;6394-6404.
84. Upton C., DeLange A. M., McFadden G. Tumorigenic poxviruses: Genomic organization and DNA sequence of the telomeric region of the Shope fibroma virus genome. Virology. 160:1987;20-30.
85. Upton C., Macen J. L., Wishart D. S., McFadden G. Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology. 179:1990;618-631.
86. Upton C., Mossman K., McFadden G. Encoding of a homolog of the interferon-γ receptor by myxoma virus. Science. 258:1992;1369-1372.
87. Weis W. I., Taylor M. E., Drickamer K. The C-type lectin superfamily in the immune system. Immunol. Rev. 163:1998;19-34.
88. Willer D. O., McFadden G., Evans D. H. The complete genome sequence of Shope (rabbit) fibroma virus. Virology. 264:1999;319-343.